Altman, T. J. & Todd, J. A. (1995) Molecular genetics of diabetes mellitus. Baillière's Clinical Endocrinology and Metabolism, 9, 631–656.
Allison, J. H. & Stewart, M. A. (1971) Reduced brain inositol in lithium treated rats. Nature (New Biology), 233, 267–268.
Baldessarini, R. J. & Tondo, L. (2000) Does lithium treatment still work? Evidence of stable responses over three decades. Archives of General Psychiatry, 57, 187–190.
Baldessarini, R. J., Tondo, L. & Hennen, J. (1997) Effects of lithium treatment and its discontinuation in Bipolar Manic–Depressive Disorders. Journal of Clinical Psychiatry, 60 (suppl. 2), 77–84.
Baraban, J. M., Worley, P. F. & Synder, S. H. (1989) Second messenger systems and psychoactive drug action; focus on the phosphoinositide system and lithium. American Journal of Psychiatry, 146, 1251–1260.
Barondes, S. H. (1998) Mood Genes: Hunting for Origins of Mania and
Depression? New York, NY: Freeman.
Bebchuk, J. M., Arfken, C. L., Dolan-Manji, S., et al (2000) A preliminary investigation of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania. Archives of General Psychiatry, 57, 95–97.
Berrettini, W., Ferraro, T., Choi, H., et al (1997) Linkage studies of bipolar illness. Archives of General Psychiatry, 54, 32–39.
Berridge, M. J. & Irvine, R. F. (1989) Inositol phosphates and cell signalling. Nature, 341, 197–205.
Berridge, M. J., Downes, C. P. & Hanley, M. R. (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochemical Journal, 206, 587–595.
Berridge, M. J., Downes, C. P. & Hanley, M. R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell, 59, 411–419.
Bhalla, U. S. & Iyengar, R. (1999) Emergent properties of networks of biological signaling pathways. Science, 283, 381–387.
Blackwood, D. H. R., He, L., Morris, S. W., et al (1996) A locus for bipolar affective disorder on chromosome 4p. Nature Genetics, 12, 427–430.
Bourne, H. R. & Nicoll, R. (1993) Molecular machines integrate coincident synaptic signals. Cell, 72, 65–75.
Boyle, W. J., Smeal, T., Defize, L. H., et al (1991) Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell, 64, 573–784.
Bruno, V., Sortino, M. A., Scapagnini, U., et al (1995) Antidegenerative effects of Mg(2+)valproate in cultured cerebellar neurons. Functional Neurology, 10, 121–130.
Bunney, W. E. & Garland-Bunney, B. L. (1987) Mechanisms of action of lithium in affective illness: basic and clinical implications. In Psychopharmacology: The Third Generation of Progress (ed. Meltzer, H. Y.), pp. 553–565. New York: Raven Press.
Catherino, W. H. & Jordan, V. C. (1993) A risk-benefit assessment of tamoxifen therapy. Drug Safety, 8, 381–397.
Catt, K. J. & Balla, T. (1989) Phosphoinositide metabolism and hormone action. Annual Review of Medicine, 40, 487–509.
Chang, M. C., Grange, E., Rabin, O., et al (1996) Lithium decreases turnover of arachidonate in several brain phospholipids. Neuroscience Letters, 22, 171–174.
Chen, G., Manji, H. K., Hawver, D. B., et al (1994) Chronic sodium valproate selectively decreases protein kinase C α and ∊ in vitro. Journal of Neurochemistry, 63, 2361–2364.
Chen, G., Yuan, P. X., Hawver, D. B., et al (1997) Increase in AP-I transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology, 16, 238–245.
Chen, G., Yuan, P. X., Jiang, Y., et al (1998) Lithium increases tyrosine hydroxylase levels both in vivo and in vitro
. Journal of Neurochemistry, 70, 1768–1771.
Chen, G., Yuan, P. X., Jiang, Y., et al (1999a) Valproate robustly enhances AP-I mediated gene expression. Molecular Brain Research, 64, 52–58.
Chen, G., Huang, L. D., Jiang, Y., et al (1999b) The mood stabilising agent valproate inhibits the activity of glycogen synthase kinase 3. Journal of Neurochemistry, 72, 1327–1330.
Chen, G., Zeng, W. Z., Jiang, L., et al (1999c) The mood stabilising agents lithium and valproate robustly increase the expression of the neuroprotective protein bcl-2 in the CNS. Journal of Neurochemistry, 72, 879–882.
Chuang, D. M. (1989) Neurotransmitter receptors and phosphoinositide turnover. Annual Review of Pharmacology and Toxicology, 29, 71–110.
Conn, P. J. & Sweatt, J. D. (1994) Protein kinase C in the nervous system. In Protein Kinase (ed. Kuo, J. F.), pp. 199–235. New York: Oxford University Press.
Couldwell, W. T., Weiss, M. H., DeGiorgio, C. M., et al (1993) Clinical and radiographic response in patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery, 32, 485–498.
Davies, J. L., Kawaguchi, Y., Bennett, S. T., et al (1994) A genome-wide search for human type I diabetes susceptibility genes. Nature, 371, 130–136.
Davis, J. M., Janicak, P. G., Hogan, D. M. (1999) Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatrica Scandinavica, 100, 406–447.
de Beer, R., van den Boogaart, A., van Ormondt, D., et al (1992) Application of tome-domain fitting in the quantification of in vivo IH spectroscopic imaging data sets. NMR in Biomedicine, 5, 171–178.
Drevets, W. C.
Videen, T. O., Price, J. I., et al (1992) A functional anatomical study of unipolar depression. Journal of Neuroscience, 12, 3628–3641.
Drevets, W. C., Price, J. L., Simpson, J. R., et al (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature, 386, 824–827.
Duman, R. S., Heninger, G. R. & Nestler, E. J. (1997) A molecular and cellular theory of depression. Archives of General Psychiatry, 54, 597–606.
Duman, R. S., Malberg, K., Nakagawa, S., et al (2000) Neuronal plasticity and survival in mood disorders. Biological Psychiatry, 48, 732–739.
Elkis, H., Friedman, W. A. & Meltzer, H. Y. (1995) Meta-analyses of studies of ventricular enlargement and cortical suicidal prominence in mood disorders. Comparisons with controls of patients with schizophrenia. Archives of General Psychiatry, 51, 735–746.
Fisher, S. K., Heacock, A. M. & Agrenoff, B. W. (1992) Inositol lipids and signal transduction in the nervous system: an update. Journal of Neurochemistry, 58, 18–38.
Flint, J. & Corley, R. (1996) Do animal models have a place in the genetic analysis of quantitative human behavioral traits?
Journal of Molecular Medicine, 74, 515–521.
Frahm, J., Merboldt, K. D. & Hanicke, W. (1987) Localised proton spectroscopy using stimulated echoes. Journal of Magnetic Resonance, 72, 502–508.
Freeman, M. P. & Stoll, A. L. (1998) Mood stabilizer combinations: a review of safety and efficacy. American Journal of Psychiatry, 155, 12–21.
Freimer, N. B., Reus, V. I., Escamilla, M. A., et al (1996) Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23. Nature Genetics, 12, 436–441.
Friedman, E., Hoau, Y. W., Levinson, D., et al (1993) Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biological Psychiatry, 33, 520–525.
Gelernter, J. (1995) Genetics of bipolar affective disorder: time for another reinvention?
American Journal of Human Genetics, 56, 1262–1266.
Ginns, E. I., Ott, J., Egeland, J. A., et al (1996) A genome-wide search for chromosomal loci linked to bipolar affective disorder in the Old Order Amish. Nature Genetics, 12, 431–435.
Ginns, E. I., St Jean, P., Philibert, R. A., et al (1998) A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. Proceedings of the National Academy of Science USA, 95, 15531–15536.
Godfrey, P. P., McClue, S. J., White, A. M., et al (1989) Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol. Biochemical Journal, 258, 621–624.
Goodwin, F. & Jamison, K. R. (1990) Manic–depressive Illness.
New York: Oxford University Press.
Guo, Z., Zhou, D. & Schultz, P. G. (2000) Designing small-molecule switches for protein–protein interactions. Science, 288, 2042–2045.
Gurling, H., Smyth, C., Kalsi, G., et al (1995) Linkage findings in bipolar disorder. Nature Genetics, 10, 8–9.
Hahn, C. G. & Friedman, E. (1999) Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorders. Bipolar Disorders, 1, 81–86.
Hallcher, L. M. & Sherman, W. R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. Journal of Biological Chemistry, 225, 10896–10901.
Hedgepath, C. M., Conrad, L. J., Zhang, J., et al (1997) Activation of the Wnt signaling pathway: a molecular mechanism for lithium action. Developmental Biology, 185, 82–91.
Huang, K. P. (1989) The mechanism of protein kinase C activation. Trends in Neurosciences, 12, 425–432.
Hughes, P. & Dragunow, M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacological Reviews, 47, 133–178.
Hyman, S. E. & Nestler, E. J. (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. American Journal of Psychiatry, 153, 151–162.
Ikeda, S., Kishida, S., Yamamoto, H., et al (1997) Axin, a negative regulator of the Wnt signalling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO Journal, 17, 1371–1384.
Ikonomov, O. & Manji, H. K. (1999) Molecular mechanisms underlying mood-stabilization in manic-depressive illness: the phenotypic challenge. American Journal of Psychiatry, 156, 1506–1514.
Jacobson, M. D. & Raff, M. (1995) Programmed cell death and Bcl-2 protection in very low oxygen. Nature, 374, 814–816.
Jope, R. S. (1999) Anti-bipolar therapy: mechanism of action of lithium. Molecular Psychiatry, 4, 117–128.
Jope, R. S. & Song, L. (1997) AP-I and NF-κPB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium. Molecular Brain Research, 50, 171–180.
Jope, R. S. & Williams, M. B. (1994) Lithium and brain signal transduction systems. Biochemical Pharmacology, 77, 429–441.
Jordan, V. C. (1994) A current view of tamoxifen for the treatment of breast cancer. British Journal of Pharmacology, 110, 507–517.
Kanno, T., Kanno, Y., Chem, L. F., et al (1998) Intrinsic transcriptional activation–inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Molecular and Cellular Biology, 18, 2444–2454.
Karin, M. & Smeal, T. (1992) Control of transcription factors by signal transduction pathways: the beginning of the end. Trends in Biochemical Sciences, 17, 418–422.
Ketter, T. A., George, M. S., Kimbrell, T. A., et al (1997) Neuroanatomical models and brain imaging studies. In Bipolar Disorder: Biological Models and Their Clinical Application (eds Joffe, R. T. & Young, L. T.), pp. 179–217
New York: Marcel Dekker.
Klampfer, L., Zhang, J., Zelenetz, A. O., et al (1996) The AMLI/ETO fusion protein activates transcription of Bcl-2. Proceedings of the National Academy of Science USA, 26, 14059–14064.
Klein, P. S. & Melton, D. A. (1996) A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Science USA, 93, 8455–8459.
Kofman, O. & Belmaker, R. H. (1990) Intracerebroventricular myo-inositol antagonizes lithium-induced suppression of rearing behaviour in rats. Brain Research, 534, 345–347.
Kofman, O. & Belmaker, R. H. (1993) Biochemical, behavioral and clinical studies of the role of inositol in lithium treatment and depression. Biological Psychiatry, 34, 839–852.
Kumer, S. C. & Vrana, K. E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. Journal of Neurochemistry, 67, 443–461.
Lawrence, M. S., Ho, D. Y., Sun, G. H., et al (1996) Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. Journal of Neuroscience, 16, 468–496.
Lenox, R. H., Watson, D. G. J. P. & Ellis, J. (1992) Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Research, 570, 333–340.
Li, P. P., Andreopoulos, S. & Warsh, J. J. (2000) Signal transduction abnormalities in bipolar affective disorder. In Cerebral Signal Transduction (ed. Reith, M. E. A.), pp. 283–312. Totowa, NJ: Humana Press.
Liang, P. & Pardee, A. B. (1992) Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science, 257, 967–971.
Liang, P., Bauer, D., Averboukh, L., et al (1995) Analysis of altered gene expression by differential display. Methods in Enzymology, 254, 304–321.
Lin, A., Smeal, T., Binetury, B., et al (1993) Control of AP-I activity by signal transduction cascades. Advances in Second Messenger and Phosphoprotein Research, 28, 225–260.
Liu, P., Tarle, S. A., Hajra, A., et al (1993) Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science, 261, 1041–1044.
Lucas, F. R. & Salinas, P. C. (1997) WNT-7A induces axonal remodelling and increases synapsin I levels in cerebellar neurons. Developmental Biology, 192, 31–44.
Manji, H. K. (1992) G proteins: implications for psychiatry. American Journal of Psychiatry, 149, 746–760.
Manji, H. K. & Potter, W. Z. (1997) Monoaminergic mechanisms. In Bipolar Disorder: Biological Models and Their Clinical Application (eds Joffe, R. T. & Young, L. T.), pp. 1–40. New York: Marcel Dekker.
Manji, H. K. & Lenox, R. H. (1999) Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic–depressive illness. Biological Psychiatry, 46, 1328–1351.
Manji, H. K. & Lenox, R. H. (2000) Signaling: cellular insights into the pathophysiology of bipolar disorder. Biological Psychiatry, 48, 518–530.
Manji, H. K., Etcheberrigaray, R., Chen, G., et al (1993) Lithium dramatically decreases mebrane-associated PKC in the hippocampus: selectivity for the alpha isozyme. Journal of Neurochemistry, 61, 2303–2310.
Manji, H. K., Potter, W. Z. & Lenox, R. H. (1995) Signal transduction pathways. Molecular targets for lithium's actions. Archives of General Psychiatry, 52, 531–543.
Manji, H. K., Bersudsky, Y., Chen, G., et al (1996) Modulation of PKC isozymes and substrates by lithium: the role of myo-inositol. Neuropsychopharmacology, 15, 370–382.
Manji, H. K., Moore, G. J. & Chen, G. (1999) Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
Biological Psychiatry, .
Manji, H. K., Chen, G., Hsiao, J. K., et al (2000a) Regulation of signal transduction pathways by mood stabilizing agents: implications for the pathophysiology and treatment of bipolar affective disorder. In Bipolar Medications: Mechanisms of Action (eds Manji, H K., Bowden, C. L. & Belmaker, R. H.), pp. 129–177. Washington, DC: American Psychiatric Press.
Manji, H. K., Moore, G. J., Rajkowska, G., et al (2000b) Neuroplasticity and cellular resilience in mood disorders. Millennium article. Molecular Psychiatry, 5, 578–593.
Manji, H. K., Drevets, W. C. & Charney, D. S. (2001) The cellular neurobiology of depression. Nature Medicine, 7, 1–7.
Merry, D. E. & Korsmeyer, S. J. (1997) Bcl-2 gene family in the nervous system. Annual Review of Neuroscience, 20, 245–267.
Moore, G. J., Bebchuk, J. M., Parrish, J. K., et al (1999) Temporal dissociation between lithium-induced CNS myo-inositol changes and clinical response in manic–depressive illness. American Journal of Psychiatry, 156, 1902–1908.
Moore, G. J., Bebchuk, J. M., Hasanat, K., et al (2000a) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2′s neurotrophic effects?
Biological Psychiatry, 48, 1–8.
Moore, G. J., Bebchuk, J. M., Wilds, I. B., et al (2000b) Lithium induced increase in human grey matter. Lancet, 356, 1241–1242.
Mork, A., Geisler, A. & Hollund, P. (1992) Effects of lithium on second messenger systems in the brain. Pharmacology and Toxicology, 71 (suppl. 1), 4–17.
Muller-Oerlinghausen, B., Ahrens, B., Grof, E., et al (1992) The effects of long-term lithium treatment on the mortality of patients with manic–depressive and schizoaffective illness. Acta Psychiatrica Scandinavica, 86, 218–222.
Nahorski, S. R., Ragan, C. I. & Challiss, R. A. J. (1991) Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends in Pharmacological Sciences, 12, 297–303.
Nahorski, S. R., Jenkinson, S. & Challiss, R. A. (1992) Disruption of phosphoinositide signalling by lithium. Biochemical Society Transactions, 20, 430–434.
Nestler, E. J. (1998) Antidepressant treatment in the 21st century. Biological Psychiatry, 44, 526–533.
Nilsson, A. (1999) Lithium therapy and suicide risk. Journal of Clinical Psychiatry, 60 (suppl. 2), 85–88.
Nishizuka, Y. (1992) Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258, 607–614.
Nonaka, S., Hough, C. J. & Chuang, D. M. (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-d-aspartate receptor-mediated calcium influx. Proceedings of the National Academy of Science USA, 95, 2642–2647.
Nurnberger, J. I. & Benettini, W. (1997) Psychiatric Genetics.
London: Chapman & Hall.
O'Connor, D. T., Kailasam, M. T. & Parmer, R. J. (1996) Complex trait genetics: new methods yield a result for essential hypertension. Journal of Clinical Investigation, 97, 1997–1998.
Ozaki, N. & Chuang, D. M. (1997) Lithium increases transcription factor binding to AP-I and cyclic AMP-responsive element in cultured neurons and rat brain. Journal of Neurochemistry, 69, 2336–2344.
Philbert, R. A., Egeland, J. A., Paul, S. M., et al (1997) The inheritance of bipolar affective disorder: abundant genes coming together. Journal of Affective Disorders, 43, 1–3.
Pontzer, N. J. & Crews, F. T. (1990) Desensitisation of muscarinic stimulated hippocampal cell firing is related to phosphoinositide hydrolysis and inhibited by lithium. Journal of Pharmacology and Experimental Therapeutics, 253, 921–929.
Post, R. M., Weiss, S. R., Clark, M., et al (2000) Lithium, carbamazepine, and valproate in affective illness: biological and neurobiological mechanisms. In Bipolar Medications: Mechanisms of Action (eds Manji, H. K., Bowden, C. L. & Belmaker, R. H.), pp. 219–248. Washington, DC: American Psychiatric Press.
Rajkowska, G. (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry, 48, 766–777.
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., et al (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry, 45, 1085–1098.
Rana, R. S. & Hokin, L. E. (1990) Role of phosphoinositides in transmembrane signalling. Physiological Reviews, 70, 115–164.
Risch, N. & Botstein, D. (1996) A manic depressive history. Nature Genetics, 12, 351–353.
Ross, E. M. (1989) Signal sorting and amplification through G protein-coupled receptors. Neuron, 3, 141–152.
Shenker, A. (1995) G protein-coupled receptor structure and function: the impact of disease causing mutations. Baillière's Clinical Endocrinology and Metabolism, 9, 427–451.
Smith, M. A., Makino, S., Altemus, M., et al (1995) Stress and antidepressants differentially regulate neurotrophin 3 mRNA expression in the locus caeruleus. Proceedings of the National Academy of Science USA, 92, 8788–8792.
Soares, J. C. & Mann, J. J. (1997) The functional neuroanatomy of mood disorders. Journal of Psychiatric Research, 1, 393–432.
Spiegel, A. M. (1998) G Proteins, Receptors, and Disease.
New Jersey: Humana Press.
Spiegel, A. M., Weinstein, L. S. & Shenker, A. (1993) Abnormalities in G protein-coupled signal transduction pathways in human disease. Journal of Clinical Investigation, 92, 1119–1125.
Stabel, S. & Parker, P. J. (1991) Protein kinase C. Pharmacology and Therapeutics, 51, 71–95.
Stambolic, V., Ruel, L. & Woodgett, J. R. (1996) Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology, 6, 1664–1668.
Taylor, C. W. (1990) The role of G proteins in transmembrane signalling. Biochemical Journal, 272, 1–13.
Thibonnier, M. & Schork, N. J. (1995) The genetics of hypertension. Current Opinion in Genetics and Development, 5, 361–370.
Tricklebank, M. D., Singh, L., Jackson, A., et al (1991) Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain. Brain Research, 588, 145–148.
Unlap, M. T. & Jope, R. S. (1997) Lithium attenuates nerve growth factor-induced activation of AP-I DNA binding activity in PC12 cells. Neuropsychopharmacology, 17, 12–17.
Van den Boogaart, A., Ala-Korpela, M., Jokisaari, J., et al (1994) Time and frequency domain analysis of NMR data compared: an application to ID IH spectra of lipoproteins. Magnetic Resonance in Medicine, 31, 347–358.
Wagner, U., Utton, M., Gallo, J. M., et al (1996) Cellular phosphorylation of tau by GSK-3beta influences tau binding to microtubules and microtubule organisation. Journal of Cell Science, 109, 1537–1543.
Wang, H. Y. & Friedman, E. (1989) Lithium inhibition of protein kinase C activation induced serotonin release. Psychopharmacology (Berlin), 99, 213–218.
Wang, H. Y. & Friedman, E. (1996) Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biological Psychiatry, 40, 568–575.
Wang, J. F., Young, L. T., Lip, P. P., et al (1997) Signal transduction abnormalities in bipolar disorder. In Bipolar Disorder: Biological Models and Their Clinical Application (eds Joffe, R. T. & Young, L. T.), pp. 41–79. New York: Marcel Dekker.
Wang, Q., Stacy, T., Miller, J. D., et al (1996) The CBFbeta subunit is essential for CBF-alpha2 (AMLI) function in vivo. Cell, 87, 697–708.
Wang, S., Wang, Q., Crute, B. E., et al (1993) Cloning and characterisation of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Molecular and Cellular Biology, 13, 3324–3339.
Warsh, J. J., Young, L. T. & Li, P. P. (2000) Guanine nucleotide binding (g) protein disturbances in bipolar affective disorder. In Bipolar Medications: Mechanisms of Action (eds Manji, H. K., Bowden, C. L. & Belmaker, R. H.), pp. 299–329. Washington, DC: American Psychiatric Press.
Watson, D. G., Watterson, J. M. & Lenox, R. H. (1998) Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers. Journal of Pharmacological and Experimental Therapeutics, 285, 307–316.
Weinstein, L. S. (1994a) Defective G proteins in human disease. In G Proteins (eds Speigel, A. M., Jones, T. L. Z., Simmonds, W. F., et al), pp. 107–117
Austin, TX: R. G. Landes.
Weinstein, L. S. (1994b) Alteration of G protein expression or function in pathophysiology. In G Proteins (eds Spiegel, A. M., Jones, T. L. Z., Simmonds, W. F., et al), pp. 118–128. Austin, TX: R. G. Landes.
Weinstein, L. S. & Shenker, A. (1993) G Protein mutations in human disease. Clinical Biochemistry, 26, 333–338.
Weng, G., Bhalla, U. S. & Lyengar, R. (1999) Complexity in biological signaling systems. Science, 284, 92–96.
Williams, M. B. & Jope, R. S. (1995) Circadian variation in rat brain AP-I DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology, 122, 363–368.
Yost, C., Torres, M., Miller, J. R., et al (1996) The axis-inducing activity, stability, and subcellular distribution of beta catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes and Development, 10, 1443–1454.
Yuan, P. X., Chen, G. & Manji, H. H. (1998) Lithium stimulates gene expression through the AP-I transcription factor pathway. Molecular Brain Research, 58, 225–230.
Yuan, P. X., Chen, G. & Manji, H. H. (1999) Lithium activates the c-Jun NH2-terminal kinases (JNKs) in vitro and in the CNS in vivo. Journal of Neurochemistry, 73, 2299–2309.